| Valproic acid | Approved Investigational | CCT5 | 22948 |
downregulated | Valproic Acid results in decreased expression of CCT5 mRNA | 5p15.2 | |
| Valproic acid | Approved Investigational | CCT5 | 22948 |
upregulated | Valproic Acid results in increased expression of CCT5 mRNA | 5p15.2 | |
| Valproic acid | Approved Investigational | CCZ1B | 221960 |
downregulated | Valproic Acid results in decreased expression of CCZ1B mRNA | 7p22.1 | |
| Valproic acid | Approved Investigational | CD109 | 135228 |
upregulated | Valproic Acid results in increased expression of CD109 mRNA | 6q13 | |
| Valproic acid | Approved Investigational | CD177 | 57126 |
upregulated | Valproic Acid results in increased expression of CD177 mRNA | 19q13.31 | |
| Valproic acid | Approved Investigational | CD1D | 912 |
upregulated | Valproic Acid results in increased expression of CD1D mRNA | 1q23.1 | |
| Valproic acid | Approved Investigational | CD200 | 4345 |
downregulated | Valproic Acid results in decreased expression of CD200 mRNA | 3q13.2 | |
| Valproic acid | Approved Investigational | CD24 | 100133941 |
upregulated | Valproic Acid results in increased expression of CD24 mRNA | 6q21 | |
| Valproic acid | Approved Investigational | CD274 | 29126 |
upregulated | Valproic Acid results in increased expression of CD274 mRNA | 9p24.1 | |
| Valproic acid | Approved Investigational | CD2BP2 | 10421 |
upregulated | Valproic Acid results in increased expression of CD2BP2 mRNA | 16p11.2 | |
| Valproic acid | Approved Investigational | CD302 | 9936 |
upregulated | Valproic Acid results in increased expression of CD302 mRNA | 2q24.2 | |
| Valproic acid | Approved Investigational | CD320 | 51293 |
upregulated | Valproic Acid results in increased expression of CD320 mRNA | 19p13.2 | |
| Valproic acid | Approved Investigational | CD36 | 948 |
upregulated | Valproic Acid results in increased expression of CD36 mRNA | 7q21.11 | |
| Valproic acid | Approved Investigational | CD40 | 958 |
upregulated | Valproic Acid results in increased expression of CD40 mRNA | 20q13.12 | |
| Valproic acid | Approved Investigational | CD44 | 960 |
upregulated | Valproic Acid results in increased expression of CD44 mRNA | 11p13 | |
| Valproic acid | Approved Investigational | CD46 | 4179 |
downregulated | Valproic Acid results in decreased expression of CD46 mRNA | 1q32.2 | |
| Valproic acid | Approved Investigational | CD47 | 961 |
upregulated | Valproic Acid results in increased expression of CD47 mRNA | 3q13.12 | |
| Valproic acid | Approved Investigational | CD55 | 1604 |
downregulated | Valproic Acid results in decreased expression of CD55 mRNA | 1q32.2 | |
| Valproic acid | Approved Investigational | CD55 | 1604 |
upregulated | Valproic Acid results in increased expression of CD55 mRNA | 1q32.2 | |
| Valproic acid | Approved Investigational | CD58 | 965 |
upregulated | Valproic Acid results in increased expression of CD58 mRNA | 1p13.1 | |
| Valproic acid | Approved Investigational | CD59 | 966 |
upregulated | Valproic Acid results in increased expression of CD59 mRNA | 11p13 | |
| Valproic acid | Approved Investigational | CD63 | 967 |
upregulated | Valproic Acid results in increased expression of CD63 mRNA | 12q13.2 | |
| Valproic acid | Approved Investigational | CD74 | 972 |
upregulated | Valproic Acid results in increased expression of CD74 mRNA | 5q33.1 | |
| Valproic acid | Approved Investigational | CD82 | 3732 |
downregulated | Valproic Acid results in decreased expression of CD82 mRNA | 11p11.2 | |
| Valproic acid | Approved Investigational | CD83 | 9308 |
upregulated | Valproic Acid results in increased expression of CD83 mRNA | 6p23 | |